TWST - Twist Bioscience Corp
IEX Last Trade
48.665
-0.185 -0.380%
Share volume: 0
Last Updated: Thu 26 Dec 2024 03:30:08 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
4.32%
PREVIOUS CLOSE
CHG
CHG%
$48.85
-0.19
-0.38%
Fundamental analysis
8%
Profitability
0%
Dept financing
5%
Liquidity
75%
Performance
0%
Performance
5 Days
2.00%
1 Month
5.39%
3 Months
7.07%
6 Months
2.24%
1 Year
33.03%
2 Year
110.87%
Key data
Stock price
$48.66
DAY RANGE
N/A - N/A
52 WEEK RANGE
$28.78 - $60.90
52 WEEK CHANGE
$27.88
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/15/2024
Company detail
CEO: Emily M. Leproust
Region: US
Website: twistbioscience.com
Employees: 990
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: twistbioscience.com
Employees: 990
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium.
Recent news